At a glance
OG Venture Partners appears in 3 funding rounds tracked by ValueAddVC since 2025, leading 2. Its most frequent sector in these rounds is Health & Biotech, and its most recent tracked deal was Neko Health's $700M Series C round (Jul 15, 2026). It co-invests most often with Atomico, General Catalyst and Lightspeed Venture Partners.
Recent changes
- Jul 15, 2026Jul 15, 2026Follow-on: Invested in Neko Health (Series C, $700M) TechCrunch
- Jun 22, 2026Jun 22, 2026Invested in Peregrine Technologies (Series D, $250M) Peregrine
- Jan 22, 2025Jan 22, 2025Invested in Neko Health (Series B, $260M) TechCrunch
Portfolio
2 totalRecent Investment Activity
3Track record: led 2 and participated in 1 of 3 tracked venture rounds · 2 in the last 12 months · led 1 Series C, 1 Series D
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Neko Health | Series C | Led | $700M | — | TechCrunch | |
| Jun 22, 2026 | Peregrine Technologies | Series D | Led | $250M | $6.8B | Peregrine | |
| Jan 22, 2025 | Neko Health | Series B | Participated | $260M | $1.8B | TechCrunch |
Sector / Stage Activity
Co-Investors
12Similar Firms
overlapping sector, stage or regionLatest Pulse
OG Venture Partners FAQ
What companies has OG Venture Partners invested in?
OG Venture Partners' portfolio includes Neko Health, Peregrine Technologies.
Who does OG Venture Partners co-invest with most?
In the rounds Value Add tracks, OG Venture Partners most often invests alongside Atomico (1 shared deal), Craft Ventures (1 shared deal), Fifth Down Capital (1 shared deal), Friends & Family Capital (1 shared deal), General Catalyst (1 shared deal).
Sources & methodologyshow
- Peregrineprimary source1 fact
- TechCrunchmajor outlet1 fact
- TechCrunchmajor outlet1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.